Cadrenal Therapeutics' James J. Ferguson III will resign as Chief Medical Officer, effective July 31, 2026, under a confidential separation agreement.
| IndividualJames J. Ferguson III | RoleChief Medical Officer | Type of ChangeResignation/Separation | Effective DateJuly 31, 2026 | ReasonResigned (as stated by Dr. Ferguson to the Board) | Replacement InfoThe Company is conducting a search for a replacement | Background DetailsNot disclosed in the filing | Board/Committee Role ChangesNot disclosed |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.